New apoptosis drugs face critical test

Nat Biotechnol. 2005 Apr;23(4):409-11. doi: 10.1038/nbt0405-409.
No abstract available

MeSH terms

  • Animals
  • Antineoplastic Agents / pharmacology*
  • Antineoplastic Agents / therapeutic use*
  • Apoptosis / drug effects*
  • Apoptosis Regulatory Proteins
  • Cell Line, Tumor
  • Clinical Trials as Topic
  • Dose-Response Relationship, Drug
  • Drug Evaluation, Preclinical
  • Humans
  • Membrane Glycoproteins / metabolism
  • Models, Biological
  • Proteins / metabolism
  • Proto-Oncogene Proteins c-bcl-2 / metabolism
  • TNF-Related Apoptosis-Inducing Ligand
  • Tumor Necrosis Factor-alpha / metabolism
  • X-Linked Inhibitor of Apoptosis Protein

Substances

  • Antineoplastic Agents
  • Apoptosis Regulatory Proteins
  • Membrane Glycoproteins
  • Proteins
  • Proto-Oncogene Proteins c-bcl-2
  • TNF-Related Apoptosis-Inducing Ligand
  • TNFSF10 protein, human
  • Tumor Necrosis Factor-alpha
  • X-Linked Inhibitor of Apoptosis Protein
  • XIAP protein, human